Skip to main content
SpringerLink
Log in

Herzmuskelerkrankungen

  • Chapter
Herz Kreislauf kompakt

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Weiterführende Literatur zu Kapitel 13.2 und 13.3

  1. Breithardt G, Kuhn H, Hammel D, Scheld HH, Seipel L, Böcker D (2002) Cardiac resynchronization therapy into the next decade: from the past to morbidity/mortality trials. Eur Heart J (Suppl D) 4:102–110

    Article  Google Scholar 

  2. Burns JC, Glodé MP (2004) Kawasaki Syndrome. Lancet 364:533–544

    Article  PubMed  Google Scholar 

  3. Cooper LT, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis — natural history and treatment. N Engl J Med 336:1860–1866

    Article  PubMed  Google Scholar 

  4. D’Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85:499–504

    Article  PubMed  CAS  Google Scholar 

  5. Doerr W (1971) Morphologie der Myokarditis. Verh Dtsch Ges Inn Med 77:301–335

    PubMed  CAS  Google Scholar 

  6. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, Hameed A, Gviazda I, Shotan A (2001) Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 24:1567–1571

    Article  Google Scholar 

  7. Elliott P (2000) Diagnosis and management of dilated cardiomyopathy. Heart 84: 106–112

    Article  PubMed  CAS  Google Scholar 

  8. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39:646–652

    Article  PubMed  CAS  Google Scholar 

  9. Grogan M, Redfield M, Baily KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ (1995) Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26:80–84

    Article  PubMed  CAS  Google Scholar 

  10. Knirsch W, Mehwald P, Dittrich S, Kececioglu D (2004) Restriktive Kardiomyopathie. Z Kardiol 93:566–573

    Article  PubMed  CAS  Google Scholar 

  11. Kuhn H, Gietzen F, Beer G, Pethig K (1993) Epidemiology of idiopathic dilated cardiomyopathy. In: Figulla H et al (eds) Idiopathic dilated cardiomyopathy. Springer, Berlin Heidelberg, p 13–25

    Google Scholar 

  12. Kuhn H, Gietzen F, Beer G (2003) Kardiomyopathien. In: Rationelle Diagnostik und Therapie in der Inneren Medizin, Leitlinien. Classen M, Dierkesmann R, Heimpel H, Koch K-M, Meyer J, Müller O-A, Specker Ch, Theiss W (Hrsg) Urban und Fischer 13 D

    Google Scholar 

  13. Kuhn H, Lawrenz T, Beer G (2005) Indikation der Herzmuskelbiopsie bei Myokarditis und dilatativer Kardiomyopathie. Med Klinik (im Druck)

    Google Scholar 

  14. Maisch B, Funcker R, Alter P, Portig I, Pankuweit S (2002) Dilatative Kardiomyopathie und Myokarditis. Aktuelle diagnostische Erfordernisse und therapeutische Möglichkeiten. Internist 43:45–65

    Article  Google Scholar 

  15. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (non-fulminant) myocarditis. N Engl J Med 342:690–695

    Article  PubMed  Google Scholar 

  16. Osterziel (2001) Genetik der dilatativen Kardiomyopathie. Z Kardiol 90:461–469

    Article  PubMed  CAS  Google Scholar 

  17. Pauschinger M, Noutsias M, Kühl U, Schultheiss HP (2004) Antivirale Therapie bei viraler Herzerkrankung. Herz 29:618–623

    Article  PubMed  Google Scholar 

  18. Peters NS, Poole-Wilson PA (1991) Myocarditis — continuing clinical and pathologic confusion. Am Heart J 121:942–947

    Article  PubMed  CAS  Google Scholar 

  19. Rauchhaus M, Müller-Werdan U (2001) Zytokine bei Herzerkrankungen. Internist 42:75–84

    Article  PubMed  CAS  Google Scholar 

  20. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G (1996) Report of the 1995 World Health Organization/International

    Google Scholar 

  21. Senac JB (1772) Traité de la structure du coeur, de son action et de ses maladies. Zitiert in: Petra Schramm, Editio rarissima 1986

    Google Scholar 

  22. Shanes JG, Ghali J, Billingham ME et al (1987) Interobserver variability in the pathologic interpretation of endomyocardial biopsy result. Circulation 75:401

    PubMed  CAS  Google Scholar 

  23. Sharma OP (2003) Diagnosis of cardiac sarcoidosis. Chest 123:19

    Article  Google Scholar 

  24. Shields RC, Tazelaar HD, Berry GJ, Cooper LT (2002) The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail 8:74–78

    Article  PubMed  Google Scholar 

  25. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinmann MM (1997) Tachycardia induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29:709–715

    Article  PubMed  CAS  Google Scholar 

  26. Society and Federation of Cardiology Tasc Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841–842

    Google Scholar 

  27. Thiene G, Corrado D, Basso C (2004) Cardiomyopathies: is it time for a molecular classification? Eur Heart J 25:1772–1775

    Article  PubMed  CAS  Google Scholar 

Weiterführende Literatur zu Kapitel 13.4

  1. Borggrefe M, Breithardt G (1998) Is the implantable defibrillator indicated in patients with hypertrophic cardiomyopathy and aborted sudden death? J Am Coll Cardiol 31:1086–1088

    Article  PubMed  CAS  Google Scholar 

  2. Breithardt OA, Beer G, Stolle B, Lieder F, Franke A, Lawrenz T, Hanrath P, Kuhn H (2005) Mid-systolic septal deceleration in hypertrophic cardiomyopathy: clinical value and insights into the pathophysiology of outflow tract obstruction by tissue Doppler echocardiography. Heart 91:379–380

    Article  PubMed  Google Scholar 

  3. Charron P, Forissier JF, Amara ME, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A, Benaiche A, Richard P, Schwartz K, Komajda M (2003) Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. Int J Cardiol 90:33–38; discussion: 38–40

    Article  PubMed  CAS  Google Scholar 

  4. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R (1990) Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation 82:507–513

    PubMed  CAS  Google Scholar 

  5. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H (2002) Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 106:454–459

    Article  PubMed  Google Scholar 

  6. Kaltenbach M, Hopf R, Kober G, Bussmann WD, Keller M, Petersen Y (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J 42:35–42

    PubMed  CAS  Google Scholar 

  7. Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 18:846–851

    PubMed  CAS  Google Scholar 

  8. Kuhn H, Gietzen F, Beer G (2003) Kardiomyopathien. In: Classen M, Dierkesmann R, Heimpel H, Koch K-M, Meyer J, Müller O-A, Specker Ch, Theiss W (Hrsg) Rationelle Diagnostik und Therapie in der Inneren Medizin, Leitlinien. Urban und Fischer 13 D

    Google Scholar 

  9. Kuhn H, Lawrenz T, Lieder F, Gietzen FH, Obergassel L, Strunk-Mueller C, Stolle B, Leuner C (2004) Alcohol septal ablation in the treatment of hypertrophic obstructive cardiomyopathy: A seven year experience. In: Maron BJ (Hrsg) Hypertrophic Cardiomyopathy. Black-well Futura, pp 279–296

    Google Scholar 

  10. Kuhn H, Loogen, F (eds) (1983) Hypertrophic obstructive and non-obstructive cardiomyopathy. Eur Heart J 4Suppl F: 1–251

    Google Scholar 

  11. Kuhn H, Seggewiss H, Gietzen FH, Boekstegers P, Neuhaus L, Seipel L (2004) Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol 93:23–31

    Article  PubMed  CAS  Google Scholar 

  12. Lawrenz T, Kuhn H (2004) Endocardial radiofrequency ablation of septal hypertrophy: A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy. Z Kardiol 93:493–499

    Article  PubMed  CAS  Google Scholar 

  13. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED (2003) ACC/ESC Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713

    Article  PubMed  Google Scholar 

  14. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. New Engl J Med 348:295–303

    Article  PubMed  Google Scholar 

  15. Oechslin E, Attenhofer J, Rojas JR, Kaufmann PA, Jenni R (2000) Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36:493–500

    Article  PubMed  CAS  Google Scholar 

  16. Reith S, Klues HG (2002) Hypertrophe Kardiomyopathie. In: Flachskamp FA (Hrsg.) Praxis der Echokardiographie. Georg Thieme, Stuttgart New York, S 234–255

    Google Scholar 

  17. Reith S, Klues HG (2003) Therapie und Risikostratifizierung der Hypertrophischen Kardiomyopathie. Z Kardiol 92:283–293

    Article  PubMed  CAS  Google Scholar 

  18. Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R (1997) Isolated non-compaction of the myocardium in adults. Mayo Clinic Proc 72:26–31

    Article  CAS  Google Scholar 

  19. Schulte HD, Borisov K, Gams E, Gramisch-Zabel H, Losse B, Schwarzkopff B (1999) Management of symptomatic hypertrophic obstructive cardiomyopathy — long term results after surgical therapy. Thorac Cardiovasc Surg 447:213–218

    Article  Google Scholar 

  20. Sengupta PP, Mohan JC, Mehta V, Jain V, Arora R, Pandian NG, Khandheria BK (2004) Comparison of echocardiographic features of noncompaction of the left ventricle in adults versus idiopathic dilated cardiomyopathy. Am J Cardiol 94:389–391

    Article  PubMed  Google Scholar 

  21. Spirito P, Rapezzi C, Bellone P, Betocchi S, Autore C, Conte MR, Bezante GP, Bruzzi P (1999) Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation 99:2132–2137

    PubMed  CAS  Google Scholar 

  22. Stollberger C, Finsterer J, Voigtlander T, Slany J (2003) Is left ventricular hypertrabeculation/noncompaction a cardiac manifestation of Fabry’s disease? Z Kardiol 92:966–969

    Article  PubMed  CAS  Google Scholar 

  23. Voigt JU, Flachskamp FA (2003) Strain and strain rate. Z Kardiol 93:249–258

    Article  Google Scholar 

  24. Wigle DE, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 92:1680–1692

    PubMed  CAS  Google Scholar 

Weiterführende Literatur zu Kapitel 13.5

  1. Beer G, Reinecke P, Gabbert HE, Hort W, Kuhn H (2002) Fabry disease in patients with hypertrophic cardiomyopathy. Z Kardiol 91:992–1002

    Article  PubMed  CAS  Google Scholar 

  2. Chimenti C, Pieroni M, Morgante E, Antuzzi D, Russo A, Russo MA, Maserie A, Frustaci A (2004) Prevalence of Fabry Disease in Female Patients with Late-Onset Hypertrophic Cardiomyopathy. Circulation 110:1047–1053

    Article  PubMed  CAS  Google Scholar 

  3. Deegan P (2002) Can we apply what we have learned from Gaucher Disease to the management of Fabry Disease? Current Medical Literature on Lysosomal Storage Diseases 2:85–91

    Google Scholar 

  4. Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27:385–410

    Article  PubMed  CAS  Google Scholar 

  5. Dubrey SW, Burke MM, Khaghani A, Hawkins PN, Yacoub MH, Banner NR (2001) Long term results of heart transplantation in patients with amyloid heart disease. Heart 85:202–207

    Article  PubMed  CAS  Google Scholar 

  6. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH (1998) The clinical features of immunoglobulin light-chain (AL) amyloidose with heart involvement. Q J Med 91:141–157

    CAS  Google Scholar 

  7. Elliott P, McKenna W J (2004) Hypertrophic cardiomyopathy. Lancet 363:1881–1891

    Article  PubMed  CAS  Google Scholar 

  8. Frenzel H, Schwarzkopff B, Hort W (2000) Amyloidose des Herzens. In: Hort W (Hrsg) Pathologische Anatomie des Herzens und seiner Hüllen, Bd 2, Pathologie des Endokards, der Kranzarterien und des Myokard. Springer, Berlin Heidelberg, S 1229–1256

    Google Scholar 

  9. Frenzel H, Schwarzkopff B, Hort W (2000) Morbus Fabry. In: Hort W (Hrsg) Pathologische Anatomie des Herzens und seiner Hüllen, Bd 2, Pathologie des Endokards, der Kranzarterien und des Myokard. Springer, Berlin Heidelberg: S 1271–1279

    Google Scholar 

  10. Gertz MA, Rajkumar SV (2002) Primary systemic amyloidosis. Current treatment options in oncology 3:261–270

    PubMed  Google Scholar 

  11. Grogan M, Gertz MA, Kyle RA, Tajik AJ (2000) Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 85:664–665

    Article  PubMed  CAS  Google Scholar 

  12. Kashyap K, Hosenpud J (1999) Cardiac Amyloidosis. Curr Treat Options Cardiovasc Med 1:209–218

    PubMed  Google Scholar 

  13. Kuhn H, Mercier J, Kohler E, Frenzel H, Hort W, Loogen F (1983) Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructice cardiomyopathy, apatypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy. Eur Heart J 4(Suppl F):93–104

    PubMed  Google Scholar 

  14. Metha A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Investigation 34:236–242

    Article  Google Scholar 

  15. Nakoa S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, Tanaka H (1995) An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. New Engl J Med 333:288–293

    Article  Google Scholar 

  16. Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, Elliott P (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105:1407–1411

    Article  PubMed  CAS  Google Scholar 

Weiterführende Literatur zu Kapitel 13.6

  1. Ahmad F (2003) The molecular genetics of arrhythmogenic right ventricular dysplasiacardiomyopathy. Clin Invest Med 26:167–178

    PubMed  CAS  Google Scholar 

  2. Burke AP, Farb A, Tashko G, Virmani R (1998) Arrhythmogenic Right Ventricular Cardiomyopathy and Fatty Replacement of the Right Ventricular Myocardium. Circulation 97:1571–1580

    PubMed  CAS  Google Scholar 

  3. Corrado D, Basso C, Schiavon M, Thiene G (1998) Screening for hypertrophic cardio-myopathy in young athletes. N Engl J Med 339:364–369

    Article  PubMed  CAS  Google Scholar 

  4. Corrado D, Thiene G (2004) Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: is there a Single Gold Standard Test? J Cardiovasc Electrophysiol 15:307–309

    Article  PubMed  Google Scholar 

  5. Coyne RF, Marchlinski F (2000) Ablation of ventricular tachycardia associated with nonischemic structural heart disease. In: Huang S, Wilber DJ (Hrsg) Radiofrequency catheter ablation of cardiac arrhythmias. Futura Publishing, New York, pp 705–735

    Google Scholar 

  6. Fontaine G, Fontaliran F, Frank R (1998) Arrhythmogenic Right Ventricular Cardiomyopathies. Clinical Form and Main Differential Diagnoses. Circulation 97:1532–1535

    PubMed  CAS  Google Scholar 

  7. Hort W (2000) Arrhythmogene rechtsventrikuläre Kardiomyopathie (ARCM). In: Hort W (Hrsg) Pathologische Anatomie des Herzens und seiner Hüllen Band2. Springer, Berlin Heidelberg, S 1141–1169

    Google Scholar 

  8. Kuhn H et al. (1983) Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy. Eur Heart J 4(Suppl F):93–104

    PubMed  Google Scholar 

  9. Kuhn H, Gietzen F H, Beer G (2002). Kardioymopathien. In: Meyer J (Hrsg) Rationelle Therapie und Diagnostik in der Inneren Medizin. Urban & Schwarzenberg, München, D13

    Google Scholar 

  10. Gietzen FH, Kuhn H (1999) Arrhythmogene rechtsventrikuläre Kardiomyopathie. In: Alexander K, Daniel W G, Diener HC (Hrsg) Thiemes Innere Medizin. Thieme, Stuttgart New York, S 1219–1225

    Google Scholar 

  11. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218

    PubMed  CAS  Google Scholar 

  12. Naccarella F, Naccarelli G, Fattori R, Nava A, Martini B, Corrada D, Masotti A, Gatti M (2001) Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: current opinions on diagnostic and therapeutic aspects. Current Opinion in Cardiology 16:8–16

    Article  PubMed  CAS  Google Scholar 

  13. Paul M, Schulze-Bahr E, Breithardt G, Wichter T (2003) Genetics of arrhythmogenic right ventricular cardiomyopathy — status quo and future perspectives. Z Kardiol 92: 128–136

    Article  PubMed  CAS  Google Scholar 

  14. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario S, Maron, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJJ, Zipes DP (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22:1374–1450

    Article  PubMed  CAS  Google Scholar 

  15. Wichter T, Borggrefe M, Haferkamp W, Chen X, Breithardt G (1992) Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 86:29–37

    PubMed  CAS  Google Scholar 

  16. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Bocker D (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single center experience of long term follow-up and complications in 60 patients. Circulation 109:1503–1508

    Article  PubMed  Google Scholar 

Weiterführende Literatur zu Kapitel 13.7

  1. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004) Guidelines on The Diagnosis and Management of Pericardial Diseases. The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 25:587–610

    Article  PubMed  Google Scholar 

  2. Sigusch HH, Figulla HR (2002) Akute Karditiden. In: Meyer J (Hrsg) Rationelle Therapie und Diagnostik in der Inneren Medizin. Urban & Schwarzenberg, München, D11

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Städt. Krankenanstalten, II. Med. Klinik, Teutoburger Straße 50, 33604, Bielefeld

    Prof. Dr. med. H. Kuhn

Authors
  1. Prof. Dr. med. H. Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Lawrenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Beer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kardiologische Fachklinik, Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Heinz-Meise-Str. 100, 36199, Rotenburg a.d.F.

    Christian Vallbracht

  2. Falltorweg 8, 63309, Dreieich

    Martin Kaltenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Kuhn, H., Lawrenz, T., Beer, G. (2006). Herzmuskelerkrankungen. In: Vallbracht, C., Kaltenbach, M. (eds) Herz Kreislauf kompakt. Steinkopff. https://doi.org/10.1007/3-7985-1615-4_26

Download citation

  • DOI: https://doi.org/10.1007/3-7985-1615-4_26

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1495-9

  • Online ISBN: 978-3-7985-1615-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation